Get the Stockscreener App
29.98
7.38%
-2.39
After Hours:
30.40
0.42
+1.40%
Precipio Inc stock is traded at $29.98, with a volume of 34,388.
It is down -7.38% in the last 24 hours and up +15.40% over the past month.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. It focuses on improving cancer diagnostics, particularly hematologic malignancies. Its objective is to enhance diagnostic accuracy and accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, and Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division and the Products Division.
See More
Previous Close:
$32.37
Open:
$32.5
24h Volume:
34,388
Relative Volume:
1.24
Market Cap:
$53.51M
Revenue:
$24.05M
Net Income/Loss:
$-363.00K
P/E Ratio:
-101.66
EPS:
-0.2949
Net Cash Flow:
$359.00K
1W Performance:
+0.60%
1M Performance:
+15.40%
6M Performance:
+47.79%
1Y Performance:
+383.08%
1-Day Range:
$29.50
$33.63
1-Week Range:
$26.18
$33.63
52-Week Range:
$5.94
$33.63
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
4 SCIENCE PARK, NEW HAVEN, CT
Compare PRPO vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
29.98 | 57.77M | 24.05M | -363.00K | 359.00K | -0.2949 |
TMO
Thermo Fisher Scientific Inc
|
472.95 | 173.46B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
174.92 | 123.60B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
579.23 | 44.71B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
349.53 | 33.65B | 3.77B | 449.25M | 516.49M | 8.7322 |
A
Agilent Technologies Inc
|
117.69 | 33.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
Precipio Inc Stock (PRPO) Latest News
[ARS] Precipio, Inc. SEC Filing - Stock Titan
Precipio (PRPO) details 2026 virtual meeting, director elections and auditor vote - Stock Titan
How (PRPO) Movements Inform Risk Allocation Models - Stock Traders Daily
PRPO (Precipio Inc.) falls 2.41% following Q2 2025 earnings release with no available consensus financial estimates.Pro Level Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai
Precipio (PRPO) Stock: Is It a Good Entry Point (-2.41%) 2026-04-18Short Term Trading - Xã Vĩnh Công
Board member for Precipio (NASDAQ: PRPO) receives 93-share grant - Stock Titan
Stock grant lifts Precipio (PRPO) director Cossman to 16,133 shares - Stock Titan
Precipio (PRPO) director paid in stock grant for Q1 board service - Stock Titan
Trading Systems Reacting to (PRPO) Volatility - Stock Traders Daily
Precipio COO Sabet Ahmed Zaki buys $530 in PRPO stock By Investing.com - Investing.com Australia
Aug Ideas: Is Precipio Inc a good ESG investment2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
Income Plays: Should I set a stop loss on Precipio Inc2026 Recap & Daily Oversold Bounce Ideas - baoquankhu1.vn
Precipio COO Sabet Ahmed Zaki buys $530 in PRPO stock - Investing.com
Precipio (PRPO) COO buys shares under 10b5-1 trading plan - Stock Titan
Volume Report: Can Precipio Inc ride the EV wavePrice Action & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Is Precipio (PRPO) Stock a Value Play | Price at $25.98, Up 1.64%Swing Entry Points - Newser
Precipio Q4 Earnings Call Highlights - Defense World
How Precipio Inc. (PRPO) Affects Rotational Strategy Timing - Stock Traders Daily
Earnings call transcript: Precipio Inc. hits financial inflection in Q4 2025 - Investing.com India
Earnings call transcript: Precipio Inc. hits financial inflection in Q4 2025 By Investing.com - Investing.com South Africa
Precipio, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Precipio (NASDAQ: PRPO) 2025 annual report shows going-concern warning and revenue concentration - Stock Titan
Trend Report: What is the cash position of Precipio Inc2026 Pullback Review & Long-Term Investment Growth Plans - baoquankhu1.vn
Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Precipio, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Precipio (NASDAQ:PRPO) & Decision Diagnostics (OTCMKTS:DECN) Head-To-Head Survey - Defense World
Ideas Watch: What is the earnings history of Precipio Inc2026 Risk Factors & Weekly High Potential Stock Alerts - baoquankhu1.vn
Is Precipio (PRPO) Stock a Top Performer | Price at $27.44, Up 0.70%Fast Rising Picks - Newser
Aug Ideas: Is Precipio Inc stock a value trap2026 Sector Review & Weekly Setup with ROI Potential - baoquankhu1.vn
Risk On: How sensitive is Precipio Inc to inflation2026 Earnings Impact & Consistent Profit Alerts - baoquankhu1.vn
PRPO SEC FilingsPrecipio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
(PRPO) and the Role of Price-Sensitive Allocations - Stock Traders Daily
If You Invested $1,000 in Precipio Inc (PRPO) - Stock Titan
CapEx per share of Precipio, Inc. – MUN:TGK - TradingView
Topline Capital Management LLC Purchases New Holdings in Precipio, Inc. $PRPO - MarketBeat
Precipio (NASDAQ:PRPO) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Precipio and Memorial Sloan-Kettering Publish Study on BCR::ABL1 Assay for Leukemia Monitoring - Clinical Lab Products
Precipio Announces Q4 and year-end 2025 Shareholder Update Call - The Manila Times
Precipio, Inc. to Host Q4 and Year-End 2025 Corporate Update Call on April 2, 2026 - Quiver Quantitative
Precipio Announces Q4 and year-end 2025 Shareholder Update Call - GlobeNewswire Inc.
Responsive Playbooks and the PRPO Inflection - Stock Traders Daily
Cancer diagnostics firm Precipio sets April 2 call on 2025 progress - Stock Titan
Precipio (PRPO) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
PRPO Earnings History & Surprises | EPS & Revenue Results | PRECIPIO INC (NASDAQ:PRPO) - ChartMill
Precipio (PRPO) Develops Groundbreaking Assay for Chronic Myeloi - GuruFocus
Precipio Announces Publication of a Joint Study with - GlobeNewswire
Activity Recap: Is now the right time to enter Precipio IncQuarterly Market Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
PRPO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Understanding the Setup: (PRPO) and Scalable Risk - Stock Traders Daily
Precipio (NASDAQ: PRPO) turns EBITDA and cash-flow positive in 2025 - Stock Titan
PRPO Achieves Positive EBITDA and Cash Flow, Eyes Long-Term Grow - GuruFocus
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.08%
2.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):